REPURPOSING ANTIPARASITIC DRUG IVERMECTIN FOR COMBINATION IMMUNOTHERAPY TO COMBAT METASTATIC BREAST CANCER

$1,759,998FY2022Department of the ArmyDOD

Beckman Research Institute Of The City Of Hope

Investigators